Abstract

There is a growing body of evidence documenting probiotic bacteria to have a beneficial effect to the host through their ability to modulate the mucosal immune system. Many probiotic bacteria can be considered to act as either immune activators or immune suppressors, which have appreciable influence on homeostasis, inflammatory- and suppressive-immunopathology. What is becoming apparent is the ability of these probiotics to modulate innate immune responses via direct or indirect effects on the signaling pathways that drive these activatory or suppressive/tolerogenic mechanisms. This review will focus on the immunomodulatory role of probiotics on signaling pathways in innate immune cells: from positive to negative regulation associated with innate immune cells driving gut mucosal functionality. Research investigations have shown probiotics to modulate innate functionality in many ways including, receptor antagonism, receptor expression, binding to and expression of adaptor proteins, expression of negative regulatory signal molecules, induction of micro-RNAs, endotoxin tolerisation and finally, the secretion of immunomodulatory proteins, lipids and metabolites. The detailed understanding of the immunomodulatory signaling effects of probiotic strains will facilitate strain-specific selective manipulation of innate cell signal mechanisms in the modulation of mucosal adjuvanticity, immune deviation and tolerisation in both healthy subjects and patients with inflammatory and suppressive pathology.

Highlights

  • Probiotics have been shown to both augment/modulate homeostatic immune defences and to ameliorate specific infectious, inflammatory and allergic diseases by modulating gut function.Probiotics are described as “Live microorganisms, which, when consumed in adequate amounts, confer a health benefit on the host” by the Food and Agricultural Organization of the United Nations and the World Health Organization [1]

  • In the context of gut homeostasis, there is a fine balance between epithelial cell proliferation, differentiation and apoptosis, allowing this dynamic cellular barrier to continually replace itself, protect from infectious pathogenic agents and to die off prior to cellular transformation resulting from long-term exposure to carcinogenic agents present in intestinal/digesta-associated water

  • Probiotics have been used to treat a range of health conditions encompassing intestinal and extraintestinal sites, including atopic dermatitis, necrotising enterocolitis, pouchitis and ulcerative colitis [142,143,144]

Read more

Summary

Introduction

Probiotics have been shown to both augment/modulate homeostatic immune defences and to ameliorate specific infectious, inflammatory and allergic diseases by modulating gut function. They are generally lactic acid bacteria (LAB), most commonly lactobacilli and bifidobacteria species, lactococcus, streptococcus and enterococcus species, as well as some non-pathogenic Escherichia coli strains are known probiotics [2] These probiotics have numerous effects on the gastrointestinal tract (GIT) and the gut-associated lymphoid tissue (GALT) where they modulate intestinal function and immune responses via augmentation of activation (adjuvanticity), and regulation/tolerisation (reviewed in [3]). These effects include the competitive exclusion of pathogens at the intestinal barrier, modulation of dendritic cell (DC) function, influencing T cell polarization and suppression of intestinal inflammation. The ways in which probiotics are recognised by innate immune receptors will be explored, with a particular emphasis on pathogen sensing, barrier integrity, anti-microbial and innate immune responses driven by intestinal epithelial cells (IECs) and the immune cells underneath this barrier such as the DCs, MΦs, neutrophils (NΦs) and natural killer cells (NKs)

Probiotic Modulation of Intestinal Epithelial Cells
Modulation of Barrier Function
Modulation of Mucosal Immunity
Probiotic modulation sensing by byTLR‐2
Activation of DCs
Probiotic Modulation of NK Cells via Cross-Talk with DCs
Probiotic Modulation of Neutrophils
Modulation of Pro-Inflammatory Cytokines
Inflammasomes
Regulation by miRNA
Probiotics as Vehicles of Endotoxin Tolerisation
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.